Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study.
Sharma A, Holz FG, Kumar N, Sarraf D, Ayachit S, Mishra C, Tufail A, Chakraborty D, Rachitskaya A, Eichenbaum D, Banker A, Parachuri N, Kumar A, Loewenstein A, Bandello F, Wakabayashi T, Woo SJ, Kuppermann BD. Sharma A, et al. Among authors: ayachit s. J Vitreoretin Dis. 2025 Feb 27:24741264251322213. doi: 10.1177/24741264251322213. Online ahead of print. J Vitreoretin Dis. 2025. PMID: 40028177 Free PMC article.
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).
Sharma A, Kaiser PK, Tadayoni R, Holz FG, Nicholson L, Vazquez-Alfageme C, Sivaprasad S, Wakabayashi T, Woo SJ, Sarraf D, Kumar N, Parachuri N, Regillo CD, Rezaei KA, Khanani AM, Bandello F, Shanamugam M, Verma L, Dogra MR, Ns M, Agarwal M, Loewenstein A, Kuppermann BD; International Retina Biosimilar Study Group (Inter BIOS Group). Sharma A, et al. Eye (Lond). 2024 Dec;38(17):3392-3395. doi: 10.1038/s41433-024-03284-x. Epub 2024 Aug 26. Eye (Lond). 2024. PMID: 39187656 No abstract available.
Dual-language testing improves bilinguals' verbal scores.
Fernandez M, Chavez MA, Cabrera Ranaldi ED, Ayachit S, Friedman M. Fernandez M, et al. Among authors: ayachit s. Clin Neuropsychol. 2025 Jan;39(1):117-128. doi: 10.1080/13854046.2024.2353409. Epub 2024 May 14. Clin Neuropsychol. 2025. PMID: 38741566
Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study).
Ueda-Consolvo T, Ishida M, Nakamura T, Yanagisawa S, Tsuboi K, Wakabayashi T, Hayashi A, Sharma A; International Retina Biosimilar Study Group (Inter BIOS Group). Ueda-Consolvo T, et al. Eye (Lond). 2024 Nov;38(16):3193-3196. doi: 10.1038/s41433-024-03220-z. Epub 2024 Jul 23. Eye (Lond). 2024. PMID: 39043816 No abstract available.
Validating a minipig model of reversible cerebral demyelination using human diagnostic modalities and electron microscopy.
Ancău M, Tanti GK, Butenschoen VM, Gempt J, Yakushev I, Nekolla S, Mühlau M, Scheunemann C, Heininger S, Löwe B, Löwe E, Baer S, Fischer J, Reiser J, Ayachit SS, Liesche-Starnecker F, Schlegel J, Matiasek K, Schifferer M, Kirschke JS, Misgeld T, Lueth T, Hemmer B. Ancău M, et al. Among authors: ayachit ss. EBioMedicine. 2024 Feb;100:104982. doi: 10.1016/j.ebiom.2024.104982. Epub 2024 Feb 1. EBioMedicine. 2024. PMID: 38306899 Free PMC article.
FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings - FORCE study.
Sharma A, Nicholson L, Vazquez-Alfageme C, Sivagnanavel V, Fausto R, Soare MC, Salamanca MB, Fabozzi L, Tsika C, Corbalan OC, Verdejo AG, Wakabayashi T, Woo SJ, Kolomeyer AM, Mansour H, Momenaei B, Regillo CD; International Retina Biosimilar Study Group (Inter BIOS Group). Sharma A, et al. Eye (Lond). 2025 Oct 2. doi: 10.1038/s41433-025-04030-7. Online ahead of print. Eye (Lond). 2025. PMID: 41039072